Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 91-100 of 145 for pancreatic cancer

Edit search filters
  1. Safety Study Of Nivolumab With Nab-Paclitaxel Plus Or Minus Gemcitabine In Pancreatic Cancer, Nab-Paclitaxel / Carboplatin In Stage IIIB/IV Non-Small Cell Lung Cancer Or Nab-Paclitaxel In Recurrent Metastatic Breast Cancer

    Scottsdale/Phoenix, AZ

  2. A Randomized Study Of Olaparib Or Placebo In Patients With Surgically Removed Pancreatic Cancer Who Have A BRCA1, BRCA2 Or PALB2 Mutation, The APOLLO Trial

    Rochester, MN

  3. Pancreatic Cancer Detection Consortium

    Rochester, MN

  4. Prospective Pancreatic Cancer Precision Oncology Treatment Outcomes Registry

    Rochester, MN

  5. Prospective Pancreatic Cancer Precision Oncology Treatment Outcomes Registry (PROCTOR)

    Rochester, MN

  6. Resectable, Borderline Resectable, And Locally Advanced Pancreatic Cancer Biorepository Of Peripheral Blood

    Rochester, MN

  7. A Study Of Pancreatic Cancer Voice Signature (PanVoS)

    Jacksonville, FL

  8. Identifying Pancreatic Cancer Risk Factor In Electronic Medical Records Using Natural Language Processing Algorithms

    Rochester, MN

  9. A Study Of Leukemia Inhibitory Factor Biomarker Monitoring Progression And Treatment Response Of Locally-advanced Unresectable And Metastatic Pancreatic Cancer Therapies

    Jacksonville, FL

  10. Monitoring Body Composition Changes In High Risk Patients For Pancreatic Cancer (PDAC)

    Jacksonville, FL

.

Mayo Clinic Footer